Search results for "pea"

showing 10 items of 6599 documents

Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence

2018

BACKGROUND Gamma-hydroxybutyrate (GHB or sodium oxybate) is both an exogenous and endogenous molecule with neuromodulator properties. In the United States, GHB is an approved drug for the treatment of narcolepsy and narcolepsy with cataplexy in adults. In some European Union countries, sodium oxybate is applied for the treatment of opioid and alcohol withdrawal. OBJECTIVE The aim of the present review was to describe the state of art of the pre-clinical research and the clinical evidence related to GHB used alone or in combination with other treatments in alcohol withdrawal syndrome and alcohol abstinence maintenance. METHOD Internationally published pre-clinical findings and clinical studi…

medicine.medical_specialtySodium Oxybatemedia_common.quotation_subjectClinical Biochemistry01 natural sciencesNaltrexone03 medical and health sciences0302 clinical medicinemedicineHumansmedia_common.cataloged_instance030216 legal & forensic medicineEuropean unionPsychiatrymedia_commonPharmacologyAlcohol Abstinencebusiness.industry010401 analytical chemistryGamma hydroxybutyrategamma-Hydroxybutyric acidAbstinencemedicine.diseaseSubstance Withdrawal Syndrome0104 chemical sciencesAlcohol withdrawal syndromeSodium OxybatebusinessAlcohol-Related DisordersCentral Nervous System AgentsAlcohol Abstinencemedicine.drugCurrent Drug Metabolism
researchProduct

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

2015

Statins are one of the most commonly prescribed drugs in clinical practice. They are usually well tolerated and effectively prevent cardiovascular events. Most adverse effects associated with statin therapy are muscle-related. The recent statement of the European Atherosclerosis Society (EAS) has focused on statin-associated muscle symptoms (SAMS), and avoided the use of the term ‘statin intolerance’. Although muscle syndromes are the most common adverse effects observed after statin therapy, excluding other side effects might underestimate the number of patients with statin intolerance, which might be observed in 10 – 15% of patients.In clinical practice, statin intolerance limits effectiv…

medicine.medical_specialtyStatinmedicine.drug_classbusiness.industrynutritional and metabolic diseasesGeneral MedicineDisease3. Good healthClinical PracticemedicineEuropean atherosclerosis societyPhysical therapyEffective treatmentPosition paperlipids (amino acids peptides and proteins)Pharmacology (medical)cardiovascular diseasesStatin therapyIntensive care medicinebusinessAdverse effectExpert Opinion on Drug Safety
researchProduct

Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction

2020

Background: Heart rate recovery (HRR) is a marker of vagal tone, which is a powerful predictor of mortality in patients with cardiovascular disease. Sacubitril/valsartan (S/V) is a treatment for heart failure with reduced ejection fraction (HFrEF), which impressively impacts cardiovascular outcome. This study aims at evaluating the effects of S/V on HRR and its correlation with cardiopulmonary indexes in HFrEF patients. Methods: Patients with HFrEF admitted to outpatients&rsquo

medicine.medical_specialtyStress testingheart failurelcsh:Medicinecardiopulmonary exercise stress testing030204 cardiovascular system & hematologyArticleSacubitril03 medical and health sciencessacubitril/valsartan heart failure heart rate recovery peak oxygen consumption autonomic function cardiopulmonary exercise stress testing0302 clinical medicineInternal medicineHeart ratemedicine030212 general & internal medicinepeak oxygen consumptionheart rate recoveryEjection fractionbusiness.industrylcsh:RGeneral Medicinemedicine.diseaseValsartansacubitril/valsartanHeart failureBreathingCardiologyautonomic functionbusinesshuman activitiesSacubitril Valsartanmedicine.drugJournal of Clinical Medicine
researchProduct

Methamphetamine abuse and meth mouth in Europe

2014

With easy chemical synthesis from its precursor, methamphetamine (MA) is now widespread in many countries. The abuse of methamphetamine is associated with several negative effects on health, because MA is a neurotoxin and a dangerous central nervous system stimulant. It changes levels of neurotransmitters in the brain, releasing dopamine and inhibiting nor epinephrine uptake which increases sympathetic nervous system activity and can lead to cardiac arrhythmia, hypertension and tachypnea. The consequences of MA abuse are clearly manifested in oral diseases (like “meth mouth”) which is characterised by extensive caries, teeth grinding with ensuing dental wear and trismus. The present review …

medicine.medical_specialtySympathetic nervous systemOral healthAmphetamine-Related DisordersOdontologíaReviewTrismusDrug abuseTachypneaMethamphetamineDevelopmental psychology“Meth mouth”DopaminemedicineHumansmedia_common.cataloged_instanceEuropean unionPsychiatryGeneral Dentistrymedia_commonEpinephrine uptakebusiness.industryMethamphetamineMedically compromised patients in Dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludMeth mouthEuropemedicine.anatomical_structureOtorhinolaryngologyTooth DiseasesUNESCO::CIENCIAS MÉDICASDrug abuse; Methamphetamine; Oral health; “Meth mouth”;Surgerymedicine.symptomMouth Diseasesbusinessmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

European guidelines on perioperative venous thromboembolism prophylaxis:Day surgery and fast-track surgery

2017

: In recent years, day surgery and fast-track surgery have experienced a continuous increase in volume. Many procedures are now performed on an outpatient protocol, including general, orthopaedic, oncological, reconstructive or vascular surgery. The management of these patients is safe, but the incidence of venous thromboembolism in this population remains unknown. Several risk factors can be identified and stratified derived from studies of inpatient surgical management (e.g. Caprini score). Recommendations for thromboprophylaxis should be tailored from the assessment of both personal and procedure-related risk factors, although with a lack of evidence for application in outpatient managem…

medicine.medical_specialtyTime FactorsPopulationMEDLINEHemorrhage030204 cardiovascular system & hematologyPerioperative Care03 medical and health sciencesPostoperative Complications0302 clinical medicineAnesthesiologyRisk FactorsJournal ArticleHumansMedicinemedia_common.cataloged_instanceEuropean UnionEuropean unioneducationEarly AmbulationSocieties Medicalmedia_common030222 orthopedicseducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)AnticoagulantsVenous ThromboembolismPerioperativeHeparin Low-Molecular-WeightVascular surgerySurgeryAnesthesiology and Pain MedicineAmbulatory Surgical ProceduresFast track surgerybusinessVenous thromboembolism
researchProduct

Osteomyelitis affecting mandible in tuberculosis patients

2012

Tuberculosis (TB) is a frequent health problem in developing nations. It has two forms pulmonary and secondary causing other kinds of TB, collectively denoted extra pulmonary tuberculosis. The prevalence of extra pulmonary TB has increased in the last couple of years. Maxillofacial manifestations of tuberculosis form nearly 10% of all extra pulmonary manifestations of the disease. Extra pulmonary TB involving maxillofacial region is our prime concern. Very few cases of TB of the temporomandibular joint (TMJ) and mandible have been reported in literature. The clinical appearance of TB infection of the TMJ has been described as unspecific, resembling arthritis, osteomyelitis, cancer or any ki…

medicine.medical_specialtyTuberculosisbusiness.industryOsteomyelitisMandibleArthritisClinical appearanceCase ReportOdontologíaDiseasemedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryTemporomandibular jointLesionmedicine.anatomical_structurestomatognathic systemClinical and Experimental DentistryUNESCO::CIENCIAS MÉDICASmedicinemedicine.symptombusinessGeneral Dentistry
researchProduct

Pea proteins oral supplementation promotes muscle thickness gains during resistance training: a double-blind, randomized, Placebo-controlled clinical…

2014

The effects of protein supplementation on muscle thickness and strength seem largely dependent on its composition. The current study aimed at comparing the impact of an oral supplementation with vegetable Pea protein (NUTRALYS®) vs. Whey protein and Placebo on biceps brachii muscle thickness and strength after a 12-week resistance training program. One hundred and sixty one males, aged 18 to 35 years were enrolled in the study and underwent 12 weeks of resistance training on upper limb muscles. According to randomization, they were included in the Pea protein (n = 53), Whey protein (n = 54) or Placebo (n = 54) group. All had to take 25 g of the proteins or placebo twice a day during the 12-…

medicine.medical_specialtyWhey proteinNutrition and DieteticsRandomizationSports medicineMuscle strengthbusiness.industryFeedingPea proteinfood and beveragesHypertrophyClinical nutritionBiceps brachiiPlaceboBicepsGastroenterologySurgeryMuscle hypertrophyInternal medicinemedicineMuscle thicknessbusinessResearch ArticleNutralysFood ScienceJournal of the International Society of Sports Nutrition
researchProduct

Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction

2021

BACKGROUND Chronotropic incompetence has shown to be associated with a decrease in exercise capacity in heart failure with preserved ejection fraction (HFpEF), yet b-blockers are commonly used in HFpEF despite the lack of robust evidence. OBJECTIVES This study aimed to evaluate the effect of b-blocker withdrawal on peak oxygen consumption (peak VO2) in patients with HFpEF and chronotropic incompetence. METHODS This is a multicenter, randomized, investigator-blinded, crossover clinical trial consisting of 2 treatment periods of 2 weeks separated by a washout period of 2 weeks. Patients with stable HFpEF, New York Heart Association functional classes II and III, previous treatment with b-bloc…

medicine.medical_specialtyanimal structuresEjection fractionpeak Vo2chronotropic incompetencebusiness.industryChronotropic incompetencepercentage of predicted peakVo2Exercise capacitymedicine.diseaseHFpEFCrossover studyHeart failureInternal medicineHeart ratemedicineCardiologyβ-blockersheart ratecrossover trialCardiology and Cardiovascular MedicinePeak vo2Heart failure with preserved ejection fractionbusiness
researchProduct

Plyometric muscular action tests in judo- and non-judo athletes

2011

The majority of explosive actions during the Judo fight occur when the athlete is trying to overcome his/her adversary via rapid execution(s) of (isolated or chained) technical manoeuvres. The aim of this study was to compare the results of two plyometric muscular action tests (i.e., Squat Jump – SJ, and Countermovement Jump – CMJ) between judoand non-judoathletes. The investigation involved a cross-sectional examination of 102 subjects (age, 21.9 ± 3.4 years) divided into 3 performance groups: a) Senior top elite judo athletes (n = 50), b) Junior elite judo athletes (n = 26) and c) Adult non-judo athletes (n = 26). Thirteen biomechanical variables (including jump height, velocity, power, f…

medicine.medical_specialtybiologyAthletesBiophysicsPhysical Therapy Sports Therapy and RehabilitationConcentricbiology.organism_classificationMuscle actionPeak velocitySquat jumpPhysical therapymedicineJumpEccentricPlyometricsOrthopedics and Sports Medicinehuman activitiesMathematicsIsokinetics and Exercise Science
researchProduct

The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control an…

2019

Background: Some recent studies have challenged the direction of causality for the association between cannabis use and psychotic disorder, suggesting that cannabis use initiation is explained by common genetic variants associated with risk of schizophrenia. We used data from the European Union Gene-Environment Interaction consortium (EUGEI) case-control study to test for the independent and combined effect of heavy cannabis use, and of Schizophrenia Polygenic risk score (SZ PRS), on risk for psychotic disorder. Methods: Genome-wide data were obtained from 492 first episode psychosis patients (FEPp) and from 787 controls of European Ancestry, and used to generate SZ PRS from the summary res…

medicine.medical_specialtybiologybusiness.industryFrequency of useCannabis usebiology.organism_classificationmedicine.disease030227 psychiatry3. Good health03 medical and health sciences0302 clinical medicineSchizophreniaFirst episode psychosisCase control analysisMedicinemedia_common.cataloged_instancePolygenic risk scoreCannabisEuropean unionbusinessPsychiatry030217 neurology & neurosurgerymedia_common
researchProduct